LANGERHANS CELL HISTIOCYTOSIS (LCH)

Clinical trials for LANGERHANS CELL HISTIOCYTOSIS (LCH) explained in plain language.

Never miss a new study

Get alerted when new LANGERHANS CELL HISTIOCYTOSIS (LCH) trials appear

Sign up with your email to follow new studies for LANGERHANS CELL HISTIOCYTOSIS (LCH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 3

UK trial aims to repurpose existing drugs for rare and Hard-to-Treat cancers

Disease control Not yet recruiting

This trial is testing if two already-approved cancer drugs, dabrafenib and trametinib, can help patients with rare cancers or common cancers that have a rare, specific genetic change called a BRAF V600 mutation. The drugs are already used for some cancers like melanoma, but resea…

Matched conditions: LANGERHANS CELL HISTIOCYTOSIS (LCH)

Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

LANGERHANS CELL HISTIOCYTOSIS (LCH)

Get alerted when new LANGERHANS CELL HISTIOCYTOSIS (LCH) trials appear

UK trial aims to repurpose existing drugs for rare and Hard-to-Treat cancers